ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
ValenzaBio Advances Pipeline of Antibody Therapeutics Toward Clinical Development for Autoimmune and Inflammatory Diseases
April 12, 2021ValenzaBio, Inc., a biopharmaceutical company developing monoclonal antibody therapeutics for autoimmune and inflammatory indications, announced the completion of a $70 million Series A financing from premier investors Fidelity Management & Research ... -
Horizon completes enrollment in TED trial early
September 14, 2018Horizon Pharma says it has completed enrollment in a confirmatory Phase III trial of teprotumumab in patients living with moderate-to-severe active thyroid...
Pharma Sources Insight January 2025
